{"id":1822,"date":"2008-01-19T09:27:03","date_gmt":"2008-01-19T13:27:03","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=1822"},"modified":"2008-01-19T09:27:03","modified_gmt":"2008-01-19T13:27:03","slug":"dermatosis-perforante-adquirida-2","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/1822","title":{"rendered":"Dermatosis Perforante Adquirida"},"content":{"rendered":"<p><strong>Presentado por:<br \/> S\u00e1nchez M, Valenzuela A,&nbsp; Matamoros G, Gonz\u00e1lez A, Henriquez J J, Sesto D, Chopite M,&nbsp; Reyes&nbsp; O, Oliver M, P\u00e9rez-Alfonzo R.<br \/> Instituto de Biomedicina, Caracas<br \/> <\/strong><\/p>\n<p><strong>Dermatosis perforante reactiva<\/strong><\/p>\n<ul>\n<li>Paciente femenina 44 a\u00f1os<\/li>\n<li>Antecedentes Personales:<\/li>\n<\/ul>\n<p>-DM desde los 38 a\u00f1os, actualmente en tto con Insulina NPH y Glibenclamida.<\/p>\n<p>-HTA en tto con Amlodipina.<\/p>\n<p><!--more--> <\/p>\n<ul>\n<li>Antecedentes familiares: No contributorios<\/li>\n<li><strong>LABORATORIO<\/strong>:<\/li>\n<\/ul>\n<p>-Hematolog\u00eda completa: Normal<\/p>\n<p>-Qu\u00edmica sangu\u00ednea: normal<\/p>\n<p>-Serolog\u00eda HIV y VDRL: Negativa<\/p>\n<p>-Factor reumatoide y Prot C react: negativos Reumatoideo: negativo.<\/p>\n<p>-Acido Urico en sangre y orina de 24 h: normal<\/p>\n<ul>\n<li><strong>PPD<\/strong>: 10  mm <strong>Esporotriquina<\/strong>: 6 mm <strong>Leishmanina<\/strong> 10 mm.<\/li>\n<li><strong>Eco de partes blanda<\/strong>: LOES en mano a descartar quistes seb\u00e1ceos.<\/li>\n<li><strong>Rx de Manos<\/strong>: Cambios inflamatorios degenerativos incipientes en ambas manos<\/li>\n<li><strong>Rx de pies<\/strong>: Hallux valgus bilateral. Cambios degenerativos en ambos pies<\/li>\n<\/ul>\n<p> <\/p>\n<table border=\"0\" cellspacing=\"2\" cellpadding=\"2\" width=\"300\">\n<tr>\n<td>&nbsp;<a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/semana1.jpg\" title=\"semana1.jpg\"><img decoding=\"async\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/semana1.miniatura.jpg\" alt=\"semana1.jpg\" \/><\/a><\/td>\n<td><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/semana2.jpg\" title=\"semana2.jpg\"><img decoding=\"async\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/semana2.miniatura.jpg\" alt=\"semana2.jpg\" \/><\/a> <\/td>\n<\/tr>\n<tr>\n<td>&nbsp;<a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/semana3.jpg\" title=\"semana3.jpg\"><img decoding=\"async\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/semana3.miniatura.jpg\" alt=\"semana3.jpg\" \/><\/a><\/td>\n<td>&nbsp;<a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/semana4.jpg\" title=\"semana4.jpg\"><img decoding=\"async\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/semana4.miniatura.jpg\" alt=\"semana4.jpg\" \/><\/a><\/td>\n<\/tr>\n<tr>\n<td>&nbsp;<a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/semana5.jpg\" title=\"semana5.jpg\"><img decoding=\"async\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/semana5.miniatura.jpg\" alt=\"semana5.jpg\" \/><\/a><\/td>\n<td>&nbsp;<\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Presentado por: S\u00e1nchez M, Valenzuela A,&nbsp; Matamoros G, Gonz\u00e1lez A, Henriquez J J, Sesto D, Chopite M,&nbsp; Reyes&nbsp; O, Oliver M, P\u00e9rez-Alfonzo R. Instituto de Biomedicina, Caracas Dermatosis perforante reactiva Paciente femenina 44 a\u00f1os Antecedentes Personales: -DM desde los 38 a\u00f1os, actualmente en tto con Insulina NPH y Glibenclamida. -HTA en tto con Amlodipina.<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[29],"tags":[],"class_list":["post-1822","post","type-post","status-publish","format-standard","","category-caso-de-la-semana"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/1822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=1822"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/1822\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=1822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=1822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=1822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}